Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now

You can switch off notifications anytime using browser settings.
Stock Analysis, IPO, Mutual Funds, Bonds & More

Macleods Pharma USA Inc recalls 31,968 bottles of diabetes drug in US

Macleods Pharma USA Inc has declared Pioglitazone Hydrochloride tablets used for treatment of diabetes in America to be superpotent which was manufactured in Baddi, Himachal Pradesh. The product was shipped to 8 distributors in US, USFDA reported.

Oct 28, 2019, 02.07 PM IST
ThinkStock Photos
New Delhi: Macleods Pharma USA Inc is recalling 31,968 bottles of Pioglitazone Hydrochloride tablets used for treatment of diabetes in the American market. The tablets being recalled are in the strength of 15 mg and have been manufactured by Macleods Pharmaceuticals Ltd in its Baddi facility in Himachal Pradesh, an enforcement report of the USFDA said.

The voluntary ongoing class II recall is on account of the product being "superpotent'', it added.

The product was shipped to 8 distributors who may have further distributed the product, the United States Food and Drug Administration (USFDA) said.

As per the USFDA, a class II recall is initiated in a situation, "in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".

The tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.

Other useful Links

Follow us on

Download et app

Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service